Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation · NCT07075718
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 2
- Target enrollment
- 110
- US sites recruiting
- 3
- Study start
- June 12, 2025
- Record last updated
- September 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Being studied: Gen 2 Travoprost Intracameral Implant; Timolol eye drops 0.5%; Sham Procedure; Placebo eye drops
Conditions: Glaucoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Diagnosis of open-angle glaucoma or ocular hypertension in the study eye
Exclusion Criteria
- Prior incisional glaucoma surgery in the study eye
- Prior argon laser trabeculoplasty (ALT) in the study eye
- Prior minimally invasive glaucoma (MIGS) surgery in the study eye
Recruiting US locations
Glaukos Investigative Site
Grand Junction, CO 81501
Site contact: Study Coordinator · 949-739-8749 · ClinicalResearch@glaukos.com
Glaukos Investigative Site
Oklahoma City, OK 73112
Site contact: Study Coordinator · 949-739-8749 · ClinicalResearch@glaukos.com
Glaukos Clinical Site
El Paso, TX 79922
Site contact: Study Coordinator · 949-739-8749 · ClinicalResearch@glaukos.com
Study contacts (from the official record)
- Study Director · 949-739-8749 · ClinicalResearch@glaukos.com
Similar studies in Colorado
All heart & blood pressure studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device
Aktiia SA
- Location
- Broomfield, CO
- Eligibility basics
- Ages 22–59
- RecruitingHealthy volunteers
Longevity Metrics AI/ML Development Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
100-Year Human Aging Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+